What is Fuller Laboratories?
Fuller Laboratories is a distinguished entity in the clinical and veterinary diagnostics arena, specializing in the creation of advanced assays for the detection of vector-borne and zoonotic diseases. Boasting over three decades of expertise, the company has earned a reputation for pioneering infectious disease immunoassays that deliver exceptional sensitivity, specificity, and repeatability. Their comprehensive product portfolio, which includes IFA, MIF, and ELISA assay formats, is designed to meet the rigorous demands of reference laboratories, serving both international and North American markets.
How much funding has Fuller Laboratories raised?
Fuller Laboratories has raised a total of $514K across 2 funding rounds:
Debt
$150K
Debt
$364K
Debt (2020): $150K with participation from PPP
Debt (2021): $364K led by PPP
What's next for Fuller Laboratories?
The recent major strategic investment signals a pivotal growth phase for Fuller Laboratories. This capital infusion is expected to accelerate the company's research and development initiatives, potentially leading to the expansion of their assay offerings and the enhancement of existing diagnostic platforms. Strategic partnerships and market penetration efforts are likely to be key priorities as the company leverages this financing to solidify its leadership in the infectious disease diagnostics market and address emerging global health challenges.
See full Fuller Laboratories company page
